Webinar

Bayer Asia PacificLiver Imaging WebinarTheme: Optimize liver cancer care and improving patient outcome

Webinar Program

Feb22
(thu)
2024

17:30-18:50 (GMT+8)Early Diagnosis

  • Diagnosis and management of pre-malignant lesions: impact on treatment choice and patient outcomes
  • Role of MRI surveillance in patients with higher HCC risk
More Details

Apr24
(wed)
2024

18:00-19:20 (GMT+8) Optimized Surgical and Interventional Therapies

  • Role of MRI before surgical HCC treatment
  • Role of MRI in patients receiving locoregional treatment
More Details

Jun25
(tue)
2024

18:00-19:30 (GMT+8) Improved Patient Management

  • Prognosis prediction of HCC based on MRI imaging: features of aggressive HCC
  • Role of MRI in HCC systemic treatment response prediction and evaluation
More Details

Aug29
(thu)
2024

18:00-19:20 (GMT+8) Liver Metastasis

  • Role of MRI imaging in liver metastasis treated with locoregional therapies
  • Role of CT and MRI in managing liver metastases from pancreatic cancer
More Details

※The agenda of the meeting may be subject to adjustments.

If you would like to register for a webinar, please contact your Bayer representative.

© 2023 Bayer (South East Asia) Pte. Ltd.

Disclaimer: This website is intended to provide information to an international audience outside the USA and UK. Not available in the U.S. and U.K.

  • PP-PRIM-ALL-0536-1,
  • PP-PRIM-SG-0126-1(06/24),
  • PP-PRIM-MY-0141-1(06/24)